Skip to content

Utilization of Reimbursed Acupuncture Therapy for Low Back Pain

Candon et al. · JAMA Network Open · 2024

📊Cross-Sectional Study👥n=6,840,497🏆High Impact - JAMA

Evidence Level

MODERATE
75/ 100
Quality
4/5
Sample
5/5
Replication
3/5
🎯

OBJECTIVE

To analyze trends in insurance-reimbursed acupuncture use in patients with low back pain

👥

WHO

American adults with low back pain and health insurance

⏱️

DURATION

Data analysis from 2010 to 2019

📍

POINTS

CPT 97810/97811 (acupuncture) and 97813/97814 (electroacupuncture)

🔬 Study Design

6840497participants
randomization

Acupuncture Users

n=106485

At least 1 reimbursed acupuncture visit

Electroacupuncture Users

n=61503

At least 1 reimbursed electroacupuncture visit

Non-users

n=6701726

No reimbursed acupuncture

⏱️ Duration: 10-year retrospective analysis

📊 Results in numbers

0.9% to 1.6%

Increase in acupuncture use

0%

Overall acupuncture use rate

OR 3.26

Higher likelihood in Asian patients

41.4% vs 52.5%

Lower opioid use among users

Percentage highlights

0.9% to 1.6%
Increase in acupuncture use
1.6%
Overall acupuncture use rate
41.4% vs 52.5%
Lower opioid use among users

📊 Outcome Comparison

Opioid Use

Acupuncture Users
41.4
Non-users
52.5

Physical Therapy

Acupuncture Users
39.2
Non-users
29.3
💬 What does this mean for you?

This large American study shows that more and more people are using acupuncture for back pain through their health plans, although it is still uncommon. Patients who use acupuncture tend to combine it with other non-drug therapies and use fewer pain medications, including opioids.

📝

Article summary

Plain-language narrative summary

This large cross-sectional study analyzed health insurance data from nearly 7 million American adults with low back pain between 2010 and 2019, revealing important patterns regarding the use of reimbursed acupuncture. The research used the Optum Clinformatics database, which includes patients with Medicare Advantage and commercial insurance, representing one of the largest analyses ever conducted of acupuncture utilization for low back pain at the population level. Results show that, although the use of reimbursed acupuncture increased steadily from 0.9% in 2010 to 1.6% in 2019, it remains relatively rare. Only 106,485 patients (1.6%) used traditional acupuncture and 61,503 (0.9%) used electroacupuncture during the study period.

The user profile reveals significant disparities: they are predominantly women (64.9%), younger (mean of 46.9 years versus 54.7 years), with higher educational attainment and household income above $100,000 annually. Asian patients were 3.26 times more likely to use acupuncture compared to White patients, while Black patients were less likely (OR 0.88). Geographically, 42.9% of users resided in the Pacific region, mainly California, which has the largest number of licensed acupuncturists. A clinically relevant finding is that acupuncture users adopted more integrated approaches to pain management: they were more likely to use physical therapy (39.2% vs 29.3%) and chiropractic care (45.1% vs 23.1%), but less dependent on pharmacological treatments.

Notably, 41.4% of acupuncture users used opioids, compared with 52.5% of non-users, suggesting that acupuncture may be part of opioid-reduction strategies. Patients with chronic low back pain (defined as two or more diagnoses separated by 90 days) were 2.39 times more likely to use acupuncture. The study identified several barriers to access: significant socioeconomic disparities, with low-income patients 41% less likely to use acupuncture; limited geographic availability of acupuncturists; and inconsistent insurance coverage. Clinical implications are important given the context of the opioid epidemic and the need for non-pharmacological alternatives for pain.

Acupuncture is recommended as a first-line treatment by major American medical organizations, including the American College of Physicians. However, limitations include the retrospective nature of the study, the inability to capture out-of-pocket visits paid directly by patients (estimated at 50-60% of the total), and the absence of data on pain severity and clinical outcomes. The study could not assess the comparative effectiveness of acupuncture versus other treatments.

Strengths

  • 1Very large, representative sample
  • 210-year longitudinal analysis
  • 3Comprehensive data on multiple treatment modalities
  • 4Robust methodology with adjustments for confounders
⚠️

Limitations

  • 1Reimbursed visits only (underestimates real use)
  • 2Cross-sectional design precludes causal inference
  • 3Absence of data on pain severity
  • 4Does not assess clinical outcomes or effectiveness
Dr. Marcus Yu Bin Pai

Expert Commentary

Dr. Marcus Yu Bin Pai

MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture

Clinical Relevance

For those who work in a musculoskeletal pain service, this study of nearly 7 million American adults with low back pain provides a valuable epidemiological snapshot of how acupuncture fits within the real therapeutic arsenal — not in the controlled setting of clinical trials, but in the chaotic flow of the health system. The finding that acupuncture users resorted to opioids in lower proportion (41.4% versus 52.5%) is directly applicable to therapeutic reasoning: acupuncture does not replace pharmacological management, but it appears to integrate strategies that reduce dependence on higher-risk analgesics. Additionally, the higher use profile in patients with chronic low back pain — two or more visits separated by 90 days — confirms that the clinician should consider acupuncture as a maintenance resource in patients with persistent low back pain, especially in those for whom the analgesic ladder has already been escalated without satisfactory control.

Notable Findings

The most striking data point is the ethnic disparity: Asian patients had an OR of 3.26 for acupuncture use compared to White patients, while Black patients showed an OR of 0.88 — a divergence that goes beyond cultural preference and likely reflects structural access barriers. In parallel, the geographic concentration in the Pacific region (42.9% of users) indicates that the availability of qualified providers strongly conditions utilization, regardless of plan coverage. Another finding worth noting: acupuncture users combined the technique with physical therapy in 39.2% of cases and with chiropractic care in 45.1%, versus 29.3% and 23.1% of non-users, respectively. This suggests that the patient who seeks acupuncture already belongs to a subgroup with an active and multimodal stance on pain management — a relevant confounding variable, but also information about the responsive profile.

From My Experience

In my practice in the musculoskeletal pain clinic at USP, I have observed exactly this pattern: the patient who adheres to acupuncture rarely comes alone — they are already in an exercise program, often in physical therapy, and generally actively question prolonged use of opioids or anti-inflammatories. I usually see the first signs of response between the third and fifth session, with measurable functional improvement around the eighth, especially in chronic nonspecific low back pain. For maintenance, we typically work with cycles of 10 to 12 sessions, with quarterly reassessment. The profile that responds best, in my experience, is the patient with myofascial pain associated with lumbar and gluteal trigger points, without an active acute radicular component. When there is overt radiculopathy with progressive neurological deficit, acupuncture comes in as an adjunct, never as the primary strategy. The finding regarding socioeconomic disparity resonates with what I see: unrestricted access to the technique within the public system is still scarce, and this limits the translation of benefits to the population that depends most on alternatives to opioids.

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture.

Full original article

Read the full scientific study

JAMA Network Open · 2024

DOI: 10.1001/jamanetworkopen.2024.30906

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.